Adderall starts working almost immediately, making it ideal for those needing quick relief. Strattera takes up to four weeks to show full effects, requiring patience.
💊
How Well They Work
Adderall generally shows stronger effects in reducing ADHD symptoms in adults, especially in short-term trials, compared to Strattera.
🚫
Risk of Misuse
Adderall has a higher risk of abuse due to its stimulant nature, while Strattera has little to no abuse potential, making it a safer choice in this regard.
Comparison
Onset of Therapeutic Action
Adderall and Strattera differ significantly in how quickly they start working. Adderall's effects are almost immediate, making it suitable for those needing quick symptom relief. Strattera, on the other hand, takes up to four weeks to reach its full therapeutic potential, requiring patience but providing a non-stimulant alternative.
Adderall
"An advantage of stimulant medication is that they have a clinical effect almost immediately after starting, while atomoxetine and the antidepressants have a delayed onset of full therapeutic action of up to four weeks."
Adderall provides almost immediate clinical effects after starting treatment.
Strattera requires up to four weeks for full therapeutic action.
Comparison
Efficacy in Symptom Reduction
Both Adderall and Strattera are effective in reducing ADHD symptoms in adults, but Adderall generally shows greater efficacy in short-term trials. Strattera is effective, though its effects may not be as pronounced as those seen with Adderall, especially in short-term use.
Adderall
"Meta-analyses have shown that effect sizes in short-term trials of adult ADHD are greater for stimulants compared with nonstimulant medications, including atomoxetine."
"Many studies have shown stimulant medications have greater efficacy. Also, stimulant medications typically have an almost immediate clinical effect, whereas atomoxetine may take several weeks for full noticeable therapeutic action."
Adderall has shown greater effect sizes in short-term trials for adult ADHD.
Strattera is effective, but generally less so than Adderall in short-term use.
Comparison
Abuse Potential and Safety
Adderall, being a stimulant, has a higher potential for abuse and dependence, which is a significant consideration for adult patients. Strattera, as a non-stimulant, carries no known risk of abuse, making it a safer option in this regard, though it may come with other side effects.
Adderall
"Due to their ability to produce powerful euphoric effects, amphetamines are common drugs of abuse."
Adderall has a high potential for abuse due to its stimulant properties.
Strattera has little to no abuse potential, making it a safer choice.
Comparison
Cardiovascular Risks
Adderall carries a higher risk of severe cardiovascular events, including sudden death, especially in adults with pre-existing heart conditions. Strattera also has cardiovascular effects, such as increased heart rate, but is generally considered to have a lower risk profile in this area.
Adderall
"Dextroamphetamine and amphetamine may cause sudden death, heart attack or stroke in adults, especially adults with heart defects or serious heart problems."
"In adult placebo-controlled trials, STRATTERA-treated subjects experienced a mean increase in heart rate of 5 beats/minute compared with placebo subjects."
Adderall may cause severe cardiovascular events, especially in those with heart issues.
Strattera increases heart rate but is considered safer for the heart overall.
Peer Reviewed Study
Study: Comparative Efficacy of ADHD Medications in Adults
The abstract reviews 51 studies on adults with ADHD, comparing medications like Adderall (amphetamines) and Strattera (atomoxetine).
It highlights that Adderall showed better efficacy compared to Strattera for short-term symptom relief based on clinicians' ratings. However, both medications were less tolerated than placebo in adults.
Adderall
Adderall (amphetamines) showed superior effectiveness in adults compared to Strattera.
Strattera
Strattera (atomoxetine) was less effective than Adderall but still better than placebo.
Peer Reviewed Study
Study: MAS XR for Adult ADHD: Efficacy and Safety
The first abstract explores the effectiveness of mixed amphetamine salts extended-release (MAS XR) in adults with ADHD. Results show that MAS XR significantly reduces ADHD symptoms, with effectiveness lasting up to 12 hours per dose.
Adverse events were mild to moderate, aligning with known stimulant side effects, and no major cardiovascular issues were observed. The abstract does not discuss Strattera (atomoxetine).
Adderall
MAS XR reduces ADHD symptoms significantly in adults, effective up to 12 hours per dose.
Peer Reviewed Study
Study: Adderall vs. Methylphenidate: ADHD Treatment Effectiveness
Several studies compared Adderall to the standard-release form of methylphenidate. The results suggest Adderall has a small but statistically significant advantage. This advantage was strongest for global ratings and was significant for clinician and parent ratings, though not for teacher ratings. These findings are specific to both fixed-dose and best-dose study designs.
Adderall
Adderall shows a small, statistically significant advantage over methylphenidate.
Evidence Summary
Duration Differences in ADHD Medications: Adderall vs. Strattera
Adderall's immediate-release form lasts about 4-6 hours, making it a shorter option for managing ADHD symptoms. The extended-release version, however, can last up to 12 hours. Strattera, on the other hand, offers consistent, all-day symptom control, which can be beneficial for those needing longer coverage.
Adderall provides a flexible dosing schedule, while Strattera's longer duration means fewer daily doses may be required.
Evidence Summary
Managing ADHD with Adderall in Complex Mental Health Cases
Adderall can help people manage ADHD symptoms, even those with co-existing mental health conditions like bipolar disorder. However, the drug’s effectiveness isn’t guaranteed for everyone, particularly those dealing with substance use disorders.
Doctors need to closely monitor patients with multiple mental health challenges to ensure Adderall provides safe and effective relief from ADHD symptoms.
Evidence Summary
Adderall’s Impact on Heart Health
Recent research has turned its attention to how Adderall, a medication frequently used for ADHD, could influence heart health. Studies are now focusing on the possible cardiovascular side effects that might arise from taking this drug. The investigations emphasize the connection between Adderall usage and its potential impact on the heart, particularly in those who rely on it regularly.
These findings are pivotal as they shed light on the cardiovascular implications of a widely prescribed medication.